Radiosurgery and stereotactic radiotherapy for intracranial meningiomas.

Rodrigo Couto Torres, Leonardo Frighetto, Antonio A F De Salles, Brian Goss, Paul Medin, Timothy Solberg, Judith Marianne Ford, Michael Selch

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

OBJECT: The authors report the evolution of linear accelerator (LINAC)-based radiosurgery in the treatment of patients with intracranial meningiomas. They describe the technical aspects as well as clinical and radiological outcomes. METHODS: The authors performed a retrospective review of 161 patients harboring 194 intracranial meningiomas treated with various types of stereotactic irradiation at their institution between May 1991 and July 2002. Clinical and radiological follow-up data (mean follow-up period 32.5 months, range 6-125 months) were obtained in 128 patients (79.5%) with 156 meningiomas (80.4%). There were 88 women and 40 men whose mean age was 57.2 years (range 18-87 years). Stereotactic irradiation was the primary treatment in 44 patients, and 84 patients underwent resection prior to radiosurgery. Stereotactic radiosurgery (SRS) was used to treat 79 lesions and fractionated stereotactic radiotherapy (SRT) was used to treat 77. The mean dose for SRS was 1567 cGy (range 1200-2285 cGy) prescribed to a mean isodose line of 66.6% (range 50-90%). Stereotactic radiotherapy was delivered using a mean dose of 4839 cGy (range 2380-5400 cGy), prescribed to a mean isodose line of 89% (range 50-90%). The mean follow-up periods were 40 and 24 months in SRS- and SRT-treated patients, respectively. Tumor control was achieved in 58 SRT-treated benign meningiomas (90%) and in 70 SRT-treated lesions (97.2%). In patients with atypical meningiomas a considerably poorer prognosis was seen. Clinical improvement or stabilization of symptoms was observed in the majority of patients. Symptomatic complications were limited to four patients (5%) treated with SRS and four (5.2%) treated with SRT. CONCLUSIONS: Stereotactic irradiation techniques have changed the neurosurgical approach to intracranial meningiomas. Either SRS or SRT delivered as a primary treatment in selected cases of skull base lesions or as an adjuvant after conservative resection has improved the management of these complex intracranial tumors.

Original languageEnglish (US)
JournalNeurosurgical Focus
Volume14
Issue number5
StatePublished - 2003

Fingerprint

Radiosurgery
Meningioma
Radiotherapy
Stereotaxic Techniques
Skull Base
Neoplasms
Therapeutics

Cite this

Torres, R. C., Frighetto, L., De Salles, A. A. F., Goss, B., Medin, P., Solberg, T., ... Selch, M. (2003). Radiosurgery and stereotactic radiotherapy for intracranial meningiomas. Neurosurgical Focus, 14(5).

Radiosurgery and stereotactic radiotherapy for intracranial meningiomas. / Torres, Rodrigo Couto; Frighetto, Leonardo; De Salles, Antonio A F; Goss, Brian; Medin, Paul; Solberg, Timothy; Ford, Judith Marianne; Selch, Michael.

In: Neurosurgical Focus, Vol. 14, No. 5, 2003.

Research output: Contribution to journalArticle

Torres, RC, Frighetto, L, De Salles, AAF, Goss, B, Medin, P, Solberg, T, Ford, JM & Selch, M 2003, 'Radiosurgery and stereotactic radiotherapy for intracranial meningiomas.', Neurosurgical Focus, vol. 14, no. 5.
Torres RC, Frighetto L, De Salles AAF, Goss B, Medin P, Solberg T et al. Radiosurgery and stereotactic radiotherapy for intracranial meningiomas. Neurosurgical Focus. 2003;14(5).
Torres, Rodrigo Couto ; Frighetto, Leonardo ; De Salles, Antonio A F ; Goss, Brian ; Medin, Paul ; Solberg, Timothy ; Ford, Judith Marianne ; Selch, Michael. / Radiosurgery and stereotactic radiotherapy for intracranial meningiomas. In: Neurosurgical Focus. 2003 ; Vol. 14, No. 5.
@article{18b2aa1494ba4eb489b91f2ec0560808,
title = "Radiosurgery and stereotactic radiotherapy for intracranial meningiomas.",
abstract = "OBJECT: The authors report the evolution of linear accelerator (LINAC)-based radiosurgery in the treatment of patients with intracranial meningiomas. They describe the technical aspects as well as clinical and radiological outcomes. METHODS: The authors performed a retrospective review of 161 patients harboring 194 intracranial meningiomas treated with various types of stereotactic irradiation at their institution between May 1991 and July 2002. Clinical and radiological follow-up data (mean follow-up period 32.5 months, range 6-125 months) were obtained in 128 patients (79.5{\%}) with 156 meningiomas (80.4{\%}). There were 88 women and 40 men whose mean age was 57.2 years (range 18-87 years). Stereotactic irradiation was the primary treatment in 44 patients, and 84 patients underwent resection prior to radiosurgery. Stereotactic radiosurgery (SRS) was used to treat 79 lesions and fractionated stereotactic radiotherapy (SRT) was used to treat 77. The mean dose for SRS was 1567 cGy (range 1200-2285 cGy) prescribed to a mean isodose line of 66.6{\%} (range 50-90{\%}). Stereotactic radiotherapy was delivered using a mean dose of 4839 cGy (range 2380-5400 cGy), prescribed to a mean isodose line of 89{\%} (range 50-90{\%}). The mean follow-up periods were 40 and 24 months in SRS- and SRT-treated patients, respectively. Tumor control was achieved in 58 SRT-treated benign meningiomas (90{\%}) and in 70 SRT-treated lesions (97.2{\%}). In patients with atypical meningiomas a considerably poorer prognosis was seen. Clinical improvement or stabilization of symptoms was observed in the majority of patients. Symptomatic complications were limited to four patients (5{\%}) treated with SRS and four (5.2{\%}) treated with SRT. CONCLUSIONS: Stereotactic irradiation techniques have changed the neurosurgical approach to intracranial meningiomas. Either SRS or SRT delivered as a primary treatment in selected cases of skull base lesions or as an adjuvant after conservative resection has improved the management of these complex intracranial tumors.",
author = "Torres, {Rodrigo Couto} and Leonardo Frighetto and {De Salles}, {Antonio A F} and Brian Goss and Paul Medin and Timothy Solberg and Ford, {Judith Marianne} and Michael Selch",
year = "2003",
language = "English (US)",
volume = "14",
journal = "Neurosurgical Focus",
issn = "1092-0684",
publisher = "American Association of Neurological Surgeons",
number = "5",

}

TY - JOUR

T1 - Radiosurgery and stereotactic radiotherapy for intracranial meningiomas.

AU - Torres, Rodrigo Couto

AU - Frighetto, Leonardo

AU - De Salles, Antonio A F

AU - Goss, Brian

AU - Medin, Paul

AU - Solberg, Timothy

AU - Ford, Judith Marianne

AU - Selch, Michael

PY - 2003

Y1 - 2003

N2 - OBJECT: The authors report the evolution of linear accelerator (LINAC)-based radiosurgery in the treatment of patients with intracranial meningiomas. They describe the technical aspects as well as clinical and radiological outcomes. METHODS: The authors performed a retrospective review of 161 patients harboring 194 intracranial meningiomas treated with various types of stereotactic irradiation at their institution between May 1991 and July 2002. Clinical and radiological follow-up data (mean follow-up period 32.5 months, range 6-125 months) were obtained in 128 patients (79.5%) with 156 meningiomas (80.4%). There were 88 women and 40 men whose mean age was 57.2 years (range 18-87 years). Stereotactic irradiation was the primary treatment in 44 patients, and 84 patients underwent resection prior to radiosurgery. Stereotactic radiosurgery (SRS) was used to treat 79 lesions and fractionated stereotactic radiotherapy (SRT) was used to treat 77. The mean dose for SRS was 1567 cGy (range 1200-2285 cGy) prescribed to a mean isodose line of 66.6% (range 50-90%). Stereotactic radiotherapy was delivered using a mean dose of 4839 cGy (range 2380-5400 cGy), prescribed to a mean isodose line of 89% (range 50-90%). The mean follow-up periods were 40 and 24 months in SRS- and SRT-treated patients, respectively. Tumor control was achieved in 58 SRT-treated benign meningiomas (90%) and in 70 SRT-treated lesions (97.2%). In patients with atypical meningiomas a considerably poorer prognosis was seen. Clinical improvement or stabilization of symptoms was observed in the majority of patients. Symptomatic complications were limited to four patients (5%) treated with SRS and four (5.2%) treated with SRT. CONCLUSIONS: Stereotactic irradiation techniques have changed the neurosurgical approach to intracranial meningiomas. Either SRS or SRT delivered as a primary treatment in selected cases of skull base lesions or as an adjuvant after conservative resection has improved the management of these complex intracranial tumors.

AB - OBJECT: The authors report the evolution of linear accelerator (LINAC)-based radiosurgery in the treatment of patients with intracranial meningiomas. They describe the technical aspects as well as clinical and radiological outcomes. METHODS: The authors performed a retrospective review of 161 patients harboring 194 intracranial meningiomas treated with various types of stereotactic irradiation at their institution between May 1991 and July 2002. Clinical and radiological follow-up data (mean follow-up period 32.5 months, range 6-125 months) were obtained in 128 patients (79.5%) with 156 meningiomas (80.4%). There were 88 women and 40 men whose mean age was 57.2 years (range 18-87 years). Stereotactic irradiation was the primary treatment in 44 patients, and 84 patients underwent resection prior to radiosurgery. Stereotactic radiosurgery (SRS) was used to treat 79 lesions and fractionated stereotactic radiotherapy (SRT) was used to treat 77. The mean dose for SRS was 1567 cGy (range 1200-2285 cGy) prescribed to a mean isodose line of 66.6% (range 50-90%). Stereotactic radiotherapy was delivered using a mean dose of 4839 cGy (range 2380-5400 cGy), prescribed to a mean isodose line of 89% (range 50-90%). The mean follow-up periods were 40 and 24 months in SRS- and SRT-treated patients, respectively. Tumor control was achieved in 58 SRT-treated benign meningiomas (90%) and in 70 SRT-treated lesions (97.2%). In patients with atypical meningiomas a considerably poorer prognosis was seen. Clinical improvement or stabilization of symptoms was observed in the majority of patients. Symptomatic complications were limited to four patients (5%) treated with SRS and four (5.2%) treated with SRT. CONCLUSIONS: Stereotactic irradiation techniques have changed the neurosurgical approach to intracranial meningiomas. Either SRS or SRT delivered as a primary treatment in selected cases of skull base lesions or as an adjuvant after conservative resection has improved the management of these complex intracranial tumors.

UR - http://www.scopus.com/inward/record.url?scp=33745001655&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745001655&partnerID=8YFLogxK

M3 - Article

C2 - 15669816

AN - SCOPUS:33745001655

VL - 14

JO - Neurosurgical Focus

JF - Neurosurgical Focus

SN - 1092-0684

IS - 5

ER -